Ethnicity and Diabetes Risk: Understanding the Disparities
Type 2 diabetes does not affect all Americans equally — and the relationship between ethnicity and diabetes risk is one of the most consistently documented and most consequential patterns in U.S. public health data. Certain racial and ethnic groups face diabetes rates two to three times higher than non-Hispanic white adults, and these disparities represent a convergence of genetic, biological, socioeconomic, and structural factors that make diabetes both more likely to develop and more difficult to manage in some communities. The CDC’s National Diabetes Statistics Report, which tracks diabetes prevalence by race and ethnicity across a nationally representative sample, consistently shows the following approximate prevalence rates for diagnosed Type 2 diabetes in U.S. adults: non-Hispanic white adults (7–8%), Asian American adults (9–10%), Hispanic/Latino adults (12–13%), non-Hispanic Black adults (12–13%), and American Indian/Alaska Native adults (15–16%). Native Hawaiian/Pacific Islander adults also face substantially elevated rates comparable to American Indian populations. Understanding the reasons behind these disparities — which include both biological differences and the health consequences of systemic inequities — is essential for both clinical care and for individual adults in high-risk groups who want to make informed decisions about screening and prevention. Our guide on diabetes risk factors covers the complete picture of individual risk factors; this article focuses specifically on how ethnicity shapes that risk landscape in the United States.
Black/African American Adults and Diabetes
Black adults in the United States face diabetes rates approximately 60–70% higher than non-Hispanic white adults, and this disparity persists after controlling for many socioeconomic variables — though socioeconomic factors remain important contributors. Several biological factors have been identified that contribute to higher diabetes risk in Black adults independent of obesity or lifestyle. Genetic studies have identified specific variants — particularly in the TCF7L2 gene and in genes affecting kidney function and salt retention — that are more common in people of West African ancestry and that contribute to both insulin resistance and hypertension. Black adults show higher rates of hypertension than any other racial group in the United States, and hypertension and insulin resistance share overlapping pathophysiological pathways (both involving renin-angiotensin system activation and inflammatory cytokines). Black adults also show evidence of higher beta cell compensation at any given level of insulin resistance — the beta cells work harder — which may help maintain normal glucose for longer but also may contribute to earlier exhaustion. Among socioeconomic contributors, Black adults in the United States face substantially higher rates of poverty and food insecurity, lower access to primary care and preventive services, higher neighborhood-level stress and exposure to environmental pollutants, and lower availability of safe spaces for physical activity in many communities — all of which independently drive diabetes risk through chronic stress, dietary quality limitations, and reduced access to screening and early intervention. Our guide on what is prediabetes explains the importance of early screening and intervention at the prediabetes stage, which is the most actionable intervention window and the one most likely to be missed in communities with lower healthcare access.
Hispanic/Latino Adults and Diabetes
Hispanic/Latino adults represent one of the largest and most diverse high-risk ethnic groups for Type 2 diabetes in the United States, with prevalence rates approximately 70% higher than non-Hispanic white adults and a particularly high rate of undiagnosed diabetes — meaning that the actual total (diagnosed plus undiagnosed) is substantially higher than the diagnosed rate alone suggests. Within the broad Hispanic/Latino category, there is significant variation in diabetes risk by specific ancestry: Puerto Rican, Dominican, and Mexican American adults tend to show the highest rates, while Cuban American and South American adults show somewhat lower (though still elevated compared to non-Hispanic whites) rates. The elevated diabetes risk in Hispanic/Latino adults involves multiple converging factors. Genetic studies identify higher prevalence of specific insulin resistance risk alleles in populations of Native American ancestry — including many Mexican American and Central American individuals who carry significant proportions of indigenous ancestry. At the population level, Hispanic/Latino communities in the U.S. also face higher rates of poverty, lower rates of health insurance coverage, language barriers to healthcare access, and cultural food practices that — while often rich in fiber and vegetables in traditional form — have been displaced by processed and fast food adoption in the context of U.S. dietary norms. Our guide on belly fat and diabetes risk is particularly relevant for this discussion because Hispanic/Latino adults show a pattern of metabolic risk at lower BMI values than non-Hispanic white adults — similar to the pattern seen in South Asian populations — meaning that standard BMI-based screening thresholds underidentify risk in this group.
Asian American Adults: High Risk at Lower Body Weight
Asian American adults present a particularly important case study in how ethnicity and diabetes risk interact, because they demonstrate that standard weight-based screening criteria — which use a BMI threshold of 25 to define overweight — substantially underdetect diabetes risk in people of Asian ancestry. Multiple lines of evidence show that Asian adults develop the same degree of insulin resistance and metabolic syndrome at BMI values 3–5 units lower than European-ancestry adults — meaning that an Asian adult at a BMI of 22 (technically “normal weight”) may have the same visceral fat burden and metabolic risk as a European-ancestry adult at BMI 25–27. The reasons include a genetic predisposition toward fat storage in visceral rather than subcutaneous depots at lower total body weight, lower skeletal muscle mass at any given BMI (reducing insulin-mediated glucose disposal capacity), and differences in pancreatic beta cell mass and secretory capacity. The American Diabetes Association now recommends screening for diabetes in Asian American adults beginning at BMI 23 rather than the standard 25 — specifically because of this lower threshold for metabolic risk. Within the broad Asian American category, South Asian adults (from India, Pakistan, Bangladesh, and neighboring countries) show the highest diabetes rates in the U.S. — sometimes exceeding 20–25% in community-based studies — reflecting both high genetic susceptibility and high rates of visceral fat at low BMI. East Asian (Chinese, Japanese, Korean) and Southeast Asian (Vietnamese, Filipino, Thai, Indonesian) adults also show elevated risk compared to non-Hispanic white adults, with Vietnamese Americans and Filipino Americans consistently showing high rates in community surveys. Our guide on weight gain and insulin resistance covers the mechanisms by which visceral fat — proportionally higher in Asian populations at any BMI — drives the insulin resistance that underlies these elevated rates.
American Indian, Alaska Native, and Pacific Islander Adults
American Indian and Alaska Native adults face the highest Type 2 diabetes rates of any racial or ethnic group in the United States, with overall prevalence exceeding 15% in national surveys and some tribal communities reporting rates of 30–50% in adults over 40. The extraordinary diabetes burden in these communities represents one of the most severe public health disparities in American medicine and reflects centuries of historical trauma, forced dietary change, loss of traditional food systems, and the ongoing health consequences of poverty and limited healthcare infrastructure on many reservations and in rural Alaska Native communities. Biologically, many indigenous peoples of the Americas carry a particularly high density of genetic variants associated with insulin resistance — the product of evolutionary pressures that favored efficient fat storage and glucose conservation in environments of periodic food scarcity. These adaptations, which were metabolically appropriate in historical contexts, become profoundly pathological in the context of the high-calorie, low-activity modern food environment. Native Hawaiian and Pacific Islander adults face similarly elevated rates, with diabetes prevalence in some communities exceeding 20%, driven by analogous combinations of genetic susceptibility and rapid dietary and lifestyle transition over recent generations. The Indian Health Service (IHS) has developed specialized diabetes prevention programs for these communities, including the Special Diabetes Program for Indians (SDPI), which has demonstrated meaningful reductions in diabetes rates in participating communities through culturally adapted lifestyle intervention programs. Our guide on family history and diabetes risk provides context for understanding how the genetic component of diabetes — which is particularly concentrated in these communities — interacts with lifestyle and environment to determine individual outcomes.
Social Determinants of Health: Why Ethnicity Is Not Just About Biology
Explaining ethnic disparities in diabetes risk primarily through biological differences would be incomplete and potentially misleading. Social determinants of health — the conditions in which people are born, grow, live, work, and age — are powerful drivers of diabetes risk that fall disproportionately on communities of color in the United States. Food insecurity and limited access to affordable whole foods (sometimes called food deserts or food swamps) concentrate in low-income communities that are disproportionately Black, Hispanic, and Native American. Healthcare access disparities — including lower rates of health insurance coverage, fewer healthcare providers in underserved communities, language barriers, and mistrust of healthcare systems shaped by historical medical exploitation — reduce the likelihood of early diabetes screening and diagnosis in high-risk communities. Neighborhood-level stress from poverty, discrimination, housing insecurity, and exposure to violence activates the chronic cortisol response that directly increases visceral fat and insulin resistance — a pathway that is as physiologically real as any genetic variant. Environmental factors including exposure to traffic-related air pollution, industrial pollutants, and endocrine-disrupting chemicals show higher concentrations in communities of color and have been linked to insulin resistance and diabetes risk. The implication for individual adults in high-risk ethnic groups is not fatalism but action: understanding that elevated risk is real and multifactorial, seeking out culturally competent diabetes prevention resources, advocating for regular screening even when healthcare access is limited, and connecting with community-based programs designed for high-risk populations. Our guide on what the A1C test means provides the specific screening information most relevant for adults in high-risk groups who want to understand their results and take appropriate next steps.
Screening Recommendations for High-Risk Ethnic Groups
Current clinical guidelines address ethnic disparities in diabetes risk with specific screening modifications for higher-risk populations. The American Diabetes Association recommendations for ethnicity-specific screening include screening Asian American adults at BMI 23 (versus the standard 25 threshold), and recommending that any adult in a high-risk racial or ethnic group be screened for prediabetes and diabetes beginning at age 35 if overweight or obese, or at any age if additional risk factors are present. The Indian Health Service recommends screening for diabetes in American Indian and Alaska Native adults beginning as early as age 10, given the extraordinary community-level prevalence rates. For adults in high-risk ethnic groups who have not had a diabetes screening in the past three years — or who have never been screened — prioritizing a fasting glucose or A1C test is one of the highest-value preventive health actions available. The rationale is straightforward: diabetes in high-risk communities is frequently undiagnosed for years, progressing silently to complications (particularly kidney disease and neuropathy, which show especially high rates in Black, Hispanic, and Native American adults) that could have been prevented with earlier identification and management. Prediabetes in these groups is also substantially underdiagnosed, meaning that people who would benefit most from structured prevention programs — like the National Diabetes Prevention Program, which is CDC-recognized and increasingly available through community organizations, workplaces, and online platforms — are not being identified. Our guide on fasting blood sugar explained covers the specific test values that define normal, prediabetes, and diabetes, and what each threshold means for follow-up timing and action. Our guide on what the A1C test means explains the alternative screening and monitoring tool that does not require fasting, making it more accessible in clinical and community settings.
Diabetes Complications and Ethnic Disparities: A Double Burden
Not only do certain ethnic groups face higher rates of developing Type 2 diabetes — they also face higher rates of serious diabetes complications once diagnosed, reflecting both longer duration of undiagnosed or undertreated disease and systematic inequities in access to ongoing diabetes care. End-stage kidney disease (diabetic nephropathy) shows a particularly striking ethnic disparity: Black adults with diabetes are approximately 3–4 times more likely to progress to kidney failure requiring dialysis than non-Hispanic white adults with diabetes, even after controlling for blood pressure and glucose control differences. This disparity reflects both a biological predisposition (genetic variants in the APOL1 gene, carried by approximately 13% of people of West African ancestry, dramatically increase kidney disease risk in the context of diabetes and hypertension) and healthcare access disparities that result in later stage of diagnosis and less consistent treatment. Hispanic/Latino adults with diabetes show higher rates of diabetic retinopathy (eye disease) than non-Hispanic white adults — partly attributable to higher rates of hypertension, which compounds diabetes-related retinal damage, and partly to less consistent access to ophthalmology screenings. Native American adults with diabetes show extremely high rates of both kidney disease and lower-extremity amputations from peripheral vascular disease — consequences of high diabetes burden, high hypertension prevalence, and historically inadequate access to preventive foot care. These disparities in complications are not inevitable consequences of ethnicity but consequences of the intersection between biological risk, socioeconomic factors, and healthcare access inequities. They reinforce the importance of early, regular monitoring for high-risk adults — because managing diabetes well from early diagnosis prevents the progression to complications that drives these disparities. Our guide on how to track your blood sugar numbers provides the home monitoring framework that allows adults with diabetes or prediabetes to maintain the active self-management associated with better outcomes in community studies.
Culturally Tailored Prevention: What Works in High-Risk Communities
Standard diabetes prevention programs — developed and tested primarily in non-Hispanic white populations — do not always translate effectively to culturally different communities, and there is growing evidence that culturally adapted versions of these programs produce better engagement, retention, and outcomes in Black, Hispanic, Asian, and Native American communities. The core content of the National Diabetes Prevention Program (the 7% weight loss target, 150 minutes of weekly activity, structured lifestyle curriculum) is evidence-based across ethnicities — the original DPP trial showed benefit in all racial and ethnic subgroups. But the delivery modality, the cultural framing of food and activity, the community-based versus clinical setting, and the language of delivery make a substantial difference in whether high-risk individuals engage with and complete these programs. Community health worker (promotora) models — using trained community members from within the target community to deliver diabetes prevention education — have shown strong effectiveness in Hispanic/Latino communities in particular, with culturally adapted dietary guidance that works within traditional food frameworks rather than against them. Faith-based diabetes prevention programs delivered through churches and mosques have shown effectiveness in Black communities, leveraging existing social networks and trust. Culturally adapted DPP programs for Asian Americans — incorporating traditional food practices, adjusting physical activity recommendations to include culturally familiar activities, and addressing the family-centered decision-making common in many Asian cultures — have shown high completion rates and meaningful risk reduction in pilot programs. For high-risk individuals seeking prevention resources, asking a healthcare provider about DPP programs specifically designed for or tested in their community — and available in their preferred language — is worth prioritizing over generic online programs that may not address cultural context. Our guide on what is prediabetes explains how to interpret the test results that qualify someone for a DPP program and what the program involves, providing the information needed to pursue this specific evidence-based resource.
Taking Action on Ethnicity-Based Diabetes Risk
For adults in high-risk racial and ethnic groups, the most important practical actions are early and regular screening, active engagement with prevention when prediabetes is found, and consistent monitoring if diabetes is diagnosed. The disparities described in this guide are not arguments for resignation — they are arguments for heightened vigilance and proactive healthcare engagement. People who know their ethnicity places them at elevated risk are in a better position than those who are unaware: they can request appropriate screening thresholds from their providers (the lower BMI cutoff for Asian Americans, for example), pursue early screening even in the absence of symptoms, and engage with prevention programs that are specifically designed for their community. The family context matters as well: if you are in a high-risk group, your children and siblings are also at elevated risk, and encouraging screening conversations within your family can enable early identification and prevention for relatives who might not otherwise act. The tools for reducing diabetes risk — regular physical activity, healthy dietary patterns, maintaining healthy weight, managing stress and sleep — are effective in all ethnic groups, and the lifestyle intervention evidence from the Diabetes Prevention Program shows that high-risk individuals benefit as much as or more than lower-risk individuals from structured prevention. The disparity is real, but so is the response. Our guide on hormones and blood sugar explains how chronic stress hormones — elevated in communities experiencing chronic social adversity — contribute directly to insulin resistance and blood sugar elevation, making stress management a health intervention as concrete as dietary change for people navigating the social conditions that amplify ethnicity-based diabetes risk. Our guide on what is blood sugar provides the foundational knowledge that empowers all adults — regardless of ethnic background — to understand their glucose metrics and engage with them meaningfully as tools for health.
Sources: CDC — National Diabetes Statistics Report 2022. | American Diabetes Association. “Standards of Medical Care in Diabetes.” Diabetes Care 2024. | National Institute of Diabetes and Digestive and Kidney Diseases — Diabetes Statistics. | Mayo Clinic — Type 2 Diabetes Risk Factors. | Menke A et al. “Prevalence of and Trends in Diabetes Among Adults in the United States.” JAMA 2015.